Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Turkish Version of Telehealth Satisfaction Survey (TeSS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04802499
Recruitment Status : Recruiting
First Posted : March 17, 2021
Last Update Posted : March 18, 2021
Sponsor:
Information provided by (Responsible Party):
Irem Hüzmeli, Mustafa Kemal University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The Turkish validity and reliability of the scale, which was created to evaluate the satisfaction of individuals, caregivers, and coordinator providing telerehabilitation services within the scope of telehealth, will be investigated.

Condition or disease Intervention/treatment
Healthy Health, Subjective Health Knowledge, Attitudes, Practice Procedure: Turkish Reliability and Validity of TESS

Detailed Description:
The telehealth satisfaction survey (TeSS) has been developed according to expectations, taking into account a device previously used in telehealth studies in Saskatchewan. The scale was initially used as part of a national study to evaluate the use of telehealth practices in improving professional access by residents of isolated Northern First Nations communities.The scale designed for telehealth services has been developed in English. Validity and reliability studies have been carried out by being translated into various languages. The Turkish validity and reliability study of the scale, originally in English, has not been conducted before.
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 150 participants
Observational Model: Ecologic or Community
Time Perspective: Prospective
Target Follow-Up Duration: 15 Days
Official Title: Investigation of the Validity and Reliability of the Turkish Version of Telehealth Satisfaction Survey (TeSS)
Actual Study Start Date : March 12, 2021
Estimated Primary Completion Date : May 12, 2022
Estimated Study Completion Date : June 12, 2022

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
persons who using telehealth (patients)
patients who have received telehealth
 Procedure: Turkish Reliability and Validity of TESS
Translation and cultural adaptation of the scale will be designed according to the appropriate procedure. Turkish data will be uploaded in the online online method. The scale will be communicated online to those who have received telerehabilitation services, caregivers and healthcare professionals who have applied it. The reliability of the questionnaire will be made by test-retest and internal consistency analysis. Volunteers will be asked to answer the questionnaire online after 5 days. After two weeks, the participants will be asked to answer the questionnaire again with the same method online with 5 days intervals. After all data are collected, validity analysis will be performed
caregivers
family member of the patients who recieved telehealth
 Procedure: Turkish Reliability and Validity of TESS
Translation and cultural adaptation of the scale will be designed according to the appropriate procedure. Turkish data will be uploaded in the online online method. The scale will be communicated online to those who have received telerehabilitation services, caregivers and healthcare professionals who have applied it. The reliability of the questionnaire will be made by test-retest and internal consistency analysis. Volunteers will be asked to answer the questionnaire online after 5 days. After two weeks, the participants will be asked to answer the questionnaire again with the same method online with 5 days intervals. After all data are collected, validity analysis will be performed
health professions
persons who use the telehealth.
 Procedure: Turkish Reliability and Validity of TESS
Translation and cultural adaptation of the scale will be designed according to the appropriate procedure. Turkish data will be uploaded in the online online method. The scale will be communicated online to those who have received telerehabilitation services, caregivers and healthcare professionals who have applied it. The reliability of the questionnaire will be made by test-retest and internal consistency analysis. Volunteers will be asked to answer the questionnaire online after 5 days. After two weeks, the participants will be asked to answer the questionnaire again with the same method online with 5 days intervals. After all data are collected, validity analysis will be performed


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Turkish Reliability and Validity of TESS (telehealth Satisfaction Survey) for patients, caregivers and health professional who use telehealth [ Time Frame: March 2021-April 2022 ]
    validation and reliability of survey in Turkish


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
telehealth patients caregivers and health professionals who practice telehealth
Criteria

Inclusion Criteria:

  • Men and woman who used telehealth

Exclusion Criteria:

  • Individuals who have the poor cooperation Mini-Mental State Exam scores of under 23
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04802499


Contacts
Layout table for location contacts
Contact: Irem Huzmeli, PhD +90 (326) 221 33 17 fztirem@gmail.com
Contact: Esra Dogru Huzmeli, Assoc prof +90 (326) 221 33 17 edogru001@hotmail.com

Locations
Layout table for location information
Turkey
Hatay Mustafa Kemal University Recruiting
Hatay, Merkez, Turkey, 31010
Contact: Irem Hüzmeli, PHD    +90 (326) 221 33 17 ext 15550    fztirem@gmail.com   
Principal Investigator: Irem Hüzmeli, PhD         
Sub-Investigator: Esra Dogru Huzmeli, PhD         
Sub-Investigator: Mehmet Karadag, PhD         
Sponsors and Collaborators
Mustafa Kemal University
Investigators
Layout table for investigator information
Study Director: Irem Huzmeli, PhD Mustafa Kemal University
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Irem Hüzmeli, Phd lecturer, Mustafa Kemal University
ClinicalTrials.gov Identifier: NCT04802499    
Other Study ID Numbers: HatayMKU
First Posted: March 17, 2021    Key Record Dates
Last Update Posted: March 18, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Irem Hüzmeli, Mustafa Kemal University:
telehealth
satisfication
telerehabilitation